Section Arrow
CVRX.NASDAQ
- CVRx
Quotes are at least 15-min delayed:2025/10/23 06:02 EDT
Pre Market
Last
 --
-- (--)
Bid
4.05
Ask
10.4
High -- 
Low -- 
Volume -- 
Regular Hours
Last
 9.93
-0.14 (-1.39%)
Day High 
10.07 
Prev. Close
10.07 
1-M High
10.49 
Volume 
107.85K 
Bid
4.05
Ask
10.4
Day Low
9.71 
Open
10.07 
1-M Low
6.98 
Market Cap 
262.55M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 9.49 
20-SMA 8.75 
50-SMA 8.01 
52-W High 18.55 
52-W Low 4.2993 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.06/-1.96
Enterprise Value
312.70M
Balance Sheet
Book Value Per Share
2.22
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
51.29M
Operating Revenue Per Share
1.35
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QSIQuantum-Si2.2-0.14-5.98%-- 
Pre Market 2.33 +0.13 +5.91%
BSXBoston Scientific Corp103.85+3.95+3.95%60.57PE
Pre Market 103.75 -0.1 -0.10%
IVFINVO Fertility Inc0.6344+0.0944+17.48%-- 
Pre Market 0.597 -0.0374 -5.90%
PACBPacific Biosciences of California1.84-0.06-3.16%-- 
Pre Market 1.96 +0.12 +6.52%
MDTMedtronic plc95.9+0.07+0.07%26.47PE
Pre Market 95.2 -0.7 -0.73%
Quotes are at least 15-min delayed:2025/10/23 06:02 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.